105.1 HLA-DQ: The dominant driver of de novo donor-specific antibody-mediated graft failure in pediatric kidney transplantation
Dr. Daniel Turudic, Croatia
105.2 ABO incompatible LRD kidney transplantation should be offered to children before listing on DD waitlist: results from a 33-year comparative OPTN study
Dr. Jelena Stojanovic, United Kingdom
105.3 Preclinical evaluation of AGT mRNA replacement therapy for primary hyperoxaluria type I disease
Prof. Taihua Yang, People's Republic of China
105.4 The role of endothelial cell senescence in protection from ischemia reperfusion injury
Dr. Marco Schmidt, Germany
105.5 Towards biopsy-free monitoring: contrast-enhanced ultrasound perfusion metrics correlate with graft pathology in pediatric kidney transplant recipients
Dr. Bernarda Viteri Baquerizo, United States
105.6 Donor derived cell-free DNA is higher in small pediatric transplant recipients receiving kidneys from obese donors